These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 470185)

  • 1. Experimental Pseudomonas infection in mice: effect of single cyclophosphamide administration on Pseudomonas infection.
    Harado S; Ishibashi T; Kitahara Y; Harada Y; Takamoto M; Sugiyama K
    Jpn J Exp Med; 1979 Feb; 49(1):43-50. PubMed ID: 470185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fractional cyclophosphamide dosage on sheep red blood cell-delayed-type hypersensitivity response in mice.
    Rondinone SN; Giovanniello OA; Barrios HA; Nota NR
    J Immunol; 1983 Apr; 130(4):1600-3. PubMed ID: 6220061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of cyclophosphamide on antibody formation in the mouse.
    Willers JM; Sluis E
    Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The modification of macrophage activity in experimental granulomas by cyclophosphamide.
    Birman EG; Mariano M
    J Pathol; 1981 Jun; 134(2):133-46. PubMed ID: 7252645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of immunopotentiating action of BCG: macrophage activation produced by BCG-infection.
    Ishibashi T; Harada S; Takamoto M; Harada Y; Yamada H; Miyazaki N; Sugiyama K
    Jpn J Exp Med; 1978 Feb; 48(1):35-40. PubMed ID: 353337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for suppressor cell activity associated with depression of contact sensitivity in Pseudomonas aeruginosa infected mice.
    Campa M; Garzelli C; Ferrannini E; Falcone G
    Clin Exp Immunol; 1976 Nov; 26(2):355-62. PubMed ID: 991463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed-type hypersensitivity to sheep red blood cells in selected lines of mice with high or low antibody responses.
    Lagrange PH; Michel JC; Hurtrel B; Thickstun PM
    Ann Immunol (Paris); 1980; 131C(3):257-77. PubMed ID: 7406440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cyclophosphamide on the immune response of BALB/c mice bearing an immunoglobulin M plasmacytoma (TEPC-183).
    Havas HF; Schiffman G
    Cancer Res; 1981 Mar; 41(3):801-7. PubMed ID: 7459867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide.
    Berd D; Maguire HC; Mastrangelo MJ
    Cancer Res; 1984 Nov; 44(11):5439-43. PubMed ID: 6488195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of suppressor-cell activity by cyclophosphamide in patients with malignant melanoma.
    Livingston PO; Cunningham-Rundles S; Marfleet G; Gnecco C; Wong GY; Schiffman G; Enker WE; Hoffman MK
    J Biol Response Mod; 1987 Aug; 6(4):392-403. PubMed ID: 2957470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide.
    Lagrange PH; Mackaness GB; Miller TE
    J Exp Med; 1974 Jun; 139(6):1529-39. PubMed ID: 4598017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental Pseudomonas infection in mice: acquired resistance against Pseudomonas septicemia and altered susceptibility in BCG infected mice.
    Ishibashi T; Harada S; Harada Y; Kitahara Y; Takamoto M; Sugiyama K
    Jpn J Exp Med; 1978 Aug; 48(4):313-20. PubMed ID: 362026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-lasting enhancement of the delayed-type hypersensitivity response to heterologous erythrocytes in mice after a single injection of cyclophosphamide.
    Bovbjerg DH; Ader R; Cohen N
    Clin Exp Immunol; 1986 Dec; 66(3):539-50. PubMed ID: 2436841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of in vivo and in vitro murine immune responses by the cyclophosphamide metabolite acrolein.
    Kawabata TT; White KL
    Cancer Res; 1988 Jan; 48(1):41-5. PubMed ID: 3257162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased infiltration by monocytes in delayed type hypersensitivity site following cyclophosphamide treatment.
    Milon G; Marchal G
    Immunology; 1978 Dec; 35(6):989-95. PubMed ID: 570175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparability of delayed hypersensitivity in various rodents. II. Jones-Mote type hypersensitivity in guinea-pigs immunized with sheep erythrocytes and its modification by cyclophosphamide or BCG pre-treatment.
    Nomoto K; Yoshida S; Himeno K
    Immunology; 1980 Sep; 41(1):83-90. PubMed ID: 7429556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulation mechanisms of the activity of T lymphocytes. Applications to infective and tumoral pathology. I. Delayed hypersensitivity and humoral response (author's transl)].
    Lagrange P
    Pathol Biol (Paris); 1976 Jan; 24(1):67-74. PubMed ID: 772569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of cutaneous leishmaniasis in the guinea-pig by cyclophosphamide.
    Belehu A; Poulter LW; Turk JL
    Clin Exp Immunol; 1976 Apr; 24(1):125-32. PubMed ID: 949870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of T-cell function and induction of antitumor immune response in T-cell-depressed spontaneously hypertensive rats by treatment with thymosin fraction 5.
    Takeichi N; Koga Y; Fujii T; Kobayashi H
    Cancer Res; 1985 Feb; 45(2):487-91. PubMed ID: 3871352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on the immunosuppressive and lympholytic activity of optical isomers of cyclophosphamide.
    Tchórzewski H; Soszyńska W; Andrzejewski W; Pankiewicz K; Stec WJ
    Arch Immunol Ther Exp (Warsz); 1983; 31(3):329-33. PubMed ID: 6228204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.